Quick answers
- What is Levophed?
- Levophed is a brand name of Norepinephrine bitartrate, a prescription medicine. The FDA NDC Directory lists 2 Levophed products in 1 strength and form.
- Who makes Levophed?
- Hospira holds the FDA application for Levophed (NDA007513, approved July 13, 1950).
- Is there a generic or store brand of Levophed?
- Yes. The FDA NDC Directory lists 10 other products with the same active ingredients, strength and form as a Levophed product, 9 of them generic. Ask your pharmacist whether one is right for you.
- Has Levophed been recalled?
- FDA enforcement reports list 2 recalls of Levophed products; the newest started August 22, 2017. A recall usually concerns specific lots, not every product.
What Levophed is
Each Levophed product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Norepinephrine bitartrate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| norepinephrine bitartrate 1 mg/mL injection, solution, concentrate (intravenous) | Levophed | 10 products, 10 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Norepinephrine bitartrate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA007513 | Hospira | July 13, 1950 | 2 |
Companies that list Levophed
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Levophed products.
- Hospira, Inc.2 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
August 22, 2017 · Class II · Terminated · D-1168-2017
Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.
Levophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL (1mg/mL), 4mL Fill in 5 mL Single dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3375-04 — Pfizer Inc.
-
May 18, 2017 · Class II · Terminated · D-0898-2017
GMP Deviation; A foreign stopper was observed during packaging of a lot of product.
Levophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only, Hospira, Inc. Lake Forest, IL --- NDC 0409-3375-04 — Hospira Inc., A Pfizer Company
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.